Koers Global Cord Blood Corporation Deutsche Boerse AG
Aandelen
6CB
KYG393421030
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 | 1,16 mld. 160 mln. 149 mln. | Omzet 2022 | 1,24 mld. 171 mln. 160 mln. | Marktkapitalisatie | 2,97 mld. 408 mln. 381 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 508 mln. 69,91 mln. 65,29 mln. | Nettowinst (verlies) 2022 | 501 mln. 68,94 mln. 64,39 mln. | EV/omzet 2021 | -2,13 x |
Nettoliquiditeiten 2021 | 6,07 mld. 836 mln. 781 mln. | Nettoliquiditeiten 2022 | 6,66 mld. 917 mln. 856 mln. | EV/omzet 2022 | -2,97 x |
K/w-verhouding 2021 |
7,1
x | K/w-verhouding 2022 |
5,93
x | Werknemers | 1.202 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 38,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01-11-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01-01-09 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Director/Board Member | 56 | 01-01-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,69% | 84,15 mld. | |
-25,20% | 74,14 mld. | |
+1,62% | 26,92 mld. | |
-10,46% | 17,15 mld. | |
-0,68% | 16,83 mld. | |
-0,73% | 15,21 mld. | |
+76,04% | 12,99 mld. | |
+72,88% | 13,3 mld. | |
+21,31% | 12,38 mld. |